Christopher Martin Aland, MD is an orthopaedic surgery in Newtown, PA with 42 years of experience. The provider is an orthopaedic surgeon is trained in the preservation, investigation and restoration of the form and function of the extremities, spine and associated structures by medical, surgical and physical means. An orthopaedic surgeon is involved with the care of patients whose musculoskeletal problems include congenital deformities, trauma, infections, tumors, metabolic disturbances of the musculoskeletal system, deformities, injuries and degenerative diseases of the spine, hands, feet, knee, hip, shoulder and elbow in children and adults. An orthopaedic surgeon is also concerned with primary and secondary muscular problems and the effects of central or peripheral nervous system lesions of the musculoskeletal system. Christopher Martin Aland, MD NPI is 1073510038. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
Graduation Year:1982
The provider's business location address is:
2700 S EAGLE RD
NEWTOWN, PA
ZIP 18940-570
Phone: (800) 321-9999
The NPI 1073510038 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
- Aspiration and/or injection of large joint or joint capsule (HCPCS:20610)
- X-ray of knee, 3 views (HCPCS:73562)
- X-ray of shoulder, minimum of 2 views (HCPCS:73030)
The enumeration date for this NPI number is 7/6/2005 and was last updated on 11/3/2021.